Biomarker Assays and Validation

Product description

Our dedicated biomarker assay team have validated a range of biomarker assays using enzyme-linked immunosorbent assay (ELISA) and electrochemiluminescence (ECL) platforms. The assays include both singleplex and multiplex platforms in multiple matrices, such as plasma, serum, cerebrospinal fluid (CSF) for use in Good Laboratory Practice (GLP) compliant preclinical and clinical development programs. With our experience in using biomarkers as surrogate endpoints in clinical research for disease states including metabolic, inflammatory, CNS, and cardiac, we can help you to obtain interim evidence about the safety and efficacy of therapeutic treatments. Our experts have the knowledge necessary to interpret results, providing insight into the drug response. The data from these studies can help you to design smaller, more efficient studies, reducing the number of subjects and shortening the time to approval of new treatments.
Read more

Specifications

Categories Laboratory and Analytical EquipmentBioanalysis; BiopharmaceuticalsBiosimilars; Contract Services - Pre Clinical Trials, Clinical Trials Stages 1-4, CRO, Clinical Data
Sales markets Western Europe; Eastern Europe; Middle East Region (e.g. UAE); Asia; Oceania; North America (USA, Canada); Africa; Central/South America
Supplied from United Kingdom

More products from Intertek Pharmaceutical Services

View all our products (81)

Products from other suppliers